Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

NCT01690299 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis
Psoriatic Arthritis

Interventions

DRUG: Apremilast
DRUG: Etanercept
DRUG: Placebo tablet
DRUG: Placebo injection

Sponsor

Amgen